New and replacement WHO standards developed by the NIBSC have been established by the WHO Expert Committee on Biological Standardisation (ECBS).
The annual meeting of the ECBS took place in October 2020 and was followed by an exceptional meeting held in December to address urgent issues related to the COVID-19 pandemic.
The purpose of these meetings was to review proposals for new and replacement WHO International Standards (IS) and International Reference Reagents (IRR). Each proposal was accompanied by data from an extensive international collaborative study, involving multiple laboratories, designed to characterise and evaluate the suitability of the candidate material.
In total, the NIBSC had eleven new standards and three replacement standards established across the two meetings. This includes three new standards that have been rapidly developed to support diagnostics, vaccine development and research into COVID-19.
Additionally, two sets of WHO written standards developed by the NIBSC supporting the production and evaluation of vaccines were also recommended for adoption.
A full list of the newly established WHO standards developed by the institute is provided below.
New and replacement standards that have not yet been added to the NIBSC catalogue will be made available over the coming months. Sign up to our mailing list and follow us on social media to receive updates.
The executive summaries of both the October and December ECBS meetings are available from the WHO website.
72nd ECBS meeting (19 to 23 October 2020)
73rd ECBS meeting (9 to 10 December 2020)
If you require more information about any of the standards listed here please contact email@example.com.